The CBD hemp stocks we’ve dug up have seen strong price gains during the past month
SmallCapPower | January 29, 2019: The passing of the U.S. Farm Bill has ended a five-decade-long ban on industrial hemp (defined as cannabis with less than 0.3% THC), allowing nationwide legal hemp production in all 50 states. With the elimination of barriers to national distribution, we have identified four CBD hemp stocks that could continue their upward share-price momentum.
*Share prices as at close January 25, 2019, data obtained from S&P Capital IQ
Charlotte’s Web Holdings (CSE:CWEB) -$19.08
Charlotte’s Web is a fully vertically-integrated, CBD-focused company with operations based in Boulder, Colorado. The Company leases or has contracts in place for over 300 acres of farmland in Colorado, Kentucky, and Oregon, which produces 250K-350K pounds of industrial hemp annually. CWEB also operates a 40,000 sq. ft manufacturing facility, a 23,000 sq. ft warehouse, packaging, and distribution center. On January 15, the Company announced that its 2018 hemp harvest was 10 times greater than its 2017 harvest. The high-quality U.S. grown hemp will be used in CWEB products for sale in 2019, implying significant revenue growth.
- 1-Month Return: 39.8%
- 3-Month Return: 67.4%
- Market Cap: $1,776.5 million
- 30-Day Average Volume: 297,000 shares
CV Sciences, Inc. (OTCPK:CVSI) – US$5.11
CV Sciences has a consumer product division focused on manufacturing, marketing, and selling CBD products. The Company also has a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD. CVSI’s initial drug candidate is CVSI-007, which combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The Company’s Plus CBD Oil™ is one of the top-selling brands of hemp-derived CBD on the market. CV Sciences recently launched a new category called Plus CBD Oil™ Gummies in Fall 2018.
- 1-Month Return: 4.3%
- 3-Month Return: 11.2%
- Market Cap: US$490.3 million
- 30-Day Average Volume: 979,000 shares
Isodiol International, Inc. (CSE:ISOL) – $1.77
Isodiol specializes in the production of pharmaceutical and consumer products with a focus on CBD nutraceuticals that are derived from hemp. Isodiol manufactures over 30 different products using 99.5%+ purity pharmaceutical-grade cannabinoids, which it distributes domestically as well as globally. The Company’s diverse product portfolio includes nutraceuticals, clinically-proven, anti-aging skin care and beverages. On December 20, 2018, the Company announced it was planning on acquiring Food Labs, Inc. Food Labs is a brand-focused innovator of hemp and cannabis-based consumer products with a flagship line of full spectrum, hemp-oil based health and wellness products.
- 1-Month Return: 39.4%
- 3-Month Return: 11.2%
- Market Cap: $72.5 million
- 30-Day Average Volume: 652,000 shares
1933 Industries Inc. (CSE:TGIF) – $0.46
1933 Industries is a vertically-integrated cannabis company with operations in the U.S. and Canada. The Company produces, packages, and markets proprietary industrial hemp/CBD-infused products, such as flowers, concentrates, extraction services, and pet products. The Company has cultivation and production assets in California, Arizona, Nevada, and Colorado. TGIF also owns distribution to a large dispensary network and now sells its products in over 100 dispensaries in California, plus another 400 locations across the U.S.
- 1-Month Return: 35.3%
- 3-Month Return: 21.1%
- Market Cap: $110.2 million
- 30-Day Average Volume: 892,000 shares
Ubika Research/SmallCapPower has received compensation from Isodiol International to provide analyst research coverage. For full disclosure please visit here >>.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below: